Comparison of two non-contemporaneous HCV-liver transplant cohorts: Strategies to improve the efficacy of antiviral therapy

Journal of Hepatology

Volumn 56, Issue 6, 2012, Pages 1310-1316

  Berenguer, Marina ^a,b,c   Aguilera, Victoria ^a,b   Rubín, Angel ^a,b   Ortíz, Cecilia ^b   Jimenez, Martina ^b   Prieto, Martín ^a,b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Calcineurin inhibitors; Cyclosporine; Fibrosis; Hepatitis C virus; Liver transplantation; Pegylated interferon; Ribavirin; Viral kinetics

Indexed keywords

CYCLOSPORIN; ERYTHROPOIETIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON; RIBAVIRIN; STEROID; TACROLIMUS;

ADULT; AGED; ANEMIA; ANTIVIRAL THERAPY; ARTICLE; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; RELAPSE; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADULT; AGED; ANTIVIRAL AGENTS; COHORT STUDIES; FEMALE; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 84861190962     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.12.031     Document Type: Article

References (18)

1. D. Samuel, X. Forns, M. Berenguer, C. Trautwein, A. Burroughs, and M. Rizzetto Report of the monothematic EASL conference on liver transplantation for viral hepatitis J Hepatol 45 2006 127 143 (Pubitemid 43850627)
2. F.P. Picciotto, G. Tritto, A.G. Lanza, L. Addario, M. De Luca, and G. Di Costanzo Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation J Hepatol 46 2007 459 465 (Pubitemid 46185706)
3. T. Bizollon, P. Pradat, J.Y. Mabrut, M. Chevallier, M. Adham, and S. Radenne Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C Am J Transplant 5 2005 1909 1913 (Pubitemid 41039864)
4. M. Berenguer, A. Palau, V. Aguilera, J.M. Rayñón, F.S. Juan, and M. Prieto Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation Am J Transplant 8 2008 679 687 (Pubitemid 351287553)
5. B.J. Veldt, J.J. Poterucha, K.D. Watt, R.H. Wiesner, J.E. Hay, and W.K. Kremers Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection Am J Transplant 8 2008 2426 2433
6. N. Selzner, E.L. Renner, M. Selzner, O. Adeyi, A. Kashfi, and G. Therapondos Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome Transplantation 88 2009 1214 1221
7. J.A. Carrion, M. Navasa, and M. Garcia-Retortillo Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study Gastroenterology 132 2007 1746 1756 (Pubitemid 46695723)
8. M. Berenguer Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin J Hepatol 49 2008 274 287
9. C.S. Wang, H.H. Ko, E.M. Yoshida, C.A. Marra, and K. Richardson Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis Am J Transplant 6 2006 1586 1599 (Pubitemid 43945798)
10. E. Xirouchakis, C. Triantos, P. Manousou, A. Sigalas, V. Calvaruso, and A. Corbani Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies J Viral Hepat 15 2008 699 709
11. M. Berenguer, V. Aguilera, M. Prieto, C. Ortiz, M. Rodríguez, and F. Gentili Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: impact of donor age and baseline cirrhosis Liver Transpl 15 2009 738 746
12. M.F. Abdelmalek, R.J. Firpi, C. Soldevila-Pico, A.I. Reed, A.W. Hemming, and C. Liu Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C Liver Transpl 10 2004 199 207 (Pubitemid 38240118)
13. B. Roche, M. Sebagh, M.L. Canfora, T. Antonini, A.M. Roque-Afonso, and V. Delvart Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis Liver Transpl 14 2008 1766 1777
14. ReViS-TC Study Group Cyclosporine a-based immunosuppression reduces relapse rate after antiviral therapy in transplanted patients with hepatitis C virus infection: a large multicenter cohort study Transplantation 15 92 2011 334 340
15. F. Xavier López-Labrador, and M. Berenguer Genomic medicine reaches HCV-related liver transplantation: Hopes and clinical and public health implications J Hepatol 55 2011 270 272
16. M. Coto-Llerena, S. Pérez-Del-Pulgar, G. Crespo, J.A. Carrión, S.M. Martínez, and J.M. Sánchez-Tapias Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation Am J Transplant 11 2011 1051 1057
17. M.R. Charlton, A. Thompson, B.J. Veldt, K. Watt, H. Tillmann, and J.J. Poterucha Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection Hepatology 53 2011 317 324
18. C.M. Lange, D. Moradpour, A. Doehring, H.A. Lehr, B. Müllhaupt, and S. Bibert Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection J Hepatol 55 2011 322 327